You Searched For "sage therapeutics" and got 20 results
Sort By:
Top Places to Visit in Manali in 2024
Nestled in the breathtaking landscapes of the Indian state of Himachal Pradesh, Manali stands as a …
Amazon is getting ready to launch Amazon Care nationally
These are Insider's biggest healthcare stories for March 15.
Lydia Ramsey Pflanzer  Â
Sylvester Stallone reflects on his son Sage Stallone's tragic death in his documentary 'Sly.' Here's what happened, and everything Stallone has said.
The "Rocky" actor's son died at the age of 36 in 2012 from coronary heart disease caused by atheros…
Eve Crosbie  Â
Sage Therapeutics craters 64% after failing a key trial for its depression drug
The $7.7 billion pharmaceutical company said Thursday that patients taking a new antidepressant for…
Daniel Strauss  Â
Top 10 places to visit in Manali in 2024
Nestled amidst the majestic Himalayas, Manali stands as a beacon of natural beauty and cultural ric…
A complete timeline of Katy Perry and Orlando Bloom's relationship and long-term engagement
Orlando Bloom and Katy Perry met in January 2016 and got engaged in 2019. The "Woman's World" singe…
Callie Ahlgrim  Â
The top doctor at a $2.7 billion pharma company developing a new depression drug says we may be 'on the cusp' of a new wave of mental-health treatments
Sage Therapeutics is developing an antidepressant that works quickly, with patients only taking the…
Yeji Jesse Lee  Â
Depression treatments haven't changed much in decades. Here are the promising new drugs that could be more precise, work faster, and help more people.
A new generation of treatments promises to help more people with depression.
Yeji Jesse Lee  Â
What are terpenes? How these cannabis compounds may influence your high
Terpenes are responsible for how plants smell, whether its citrusy or peppery. Now, some believe th…
Lia Tabackman,Mia Hazle  Â
Employees at top biotech companies can get paid more than $800,000 a year. Here are the companies where workers make the most.
The US also requires companies to calculate out a ratio illustrating the difference between the med…
Lydia Ramsey  Â
Regulators just approved a new depression drug with the potential to be a game-changer
One of the biggest potential upsides of Sage's drug is the fact that it would not need to be taken …
Erin Brodwin  Â
A drug that works differently from all existing depression drugs just got a big boost
In results from its latest clinical trial on Monday, the drug, called Sage 217, appeared to relieve…
Erin Brodwin  Â
A CEO sent his stock surging 15% when he likened his new depression drug to an antibiotic - but a consultant to the company told us it won't work that way
A once-only course of treatment is essentially unheard of for depression or for any other chronic d…
Erin Brodwin  Â
Dispensed: What we saw at JPMorgan's big healthcare investor conference
With that, I'm going to go recover from the red-eye flight I somehow thought was a good idea. Pleas…
Lydia Ramsey  Â
We'll get you caught up on all the news you missed at the year's biggest healthcare investor conference
Thousands of investors, Wall Street analysts, execs, and of course, journalists, converged on San F…
Zachary Tracer  Â
A new drug to treat a condition that affects around 600,000 new moms each year just passed a major hurdle
Giving birth can trigger emotions for new moms that include depression, which often goes away after…
Lydia Ramsey  Â
A fresh crop of promising drugs is poised to change the way depression is treated for the first time in decades. Here are the ones to watch in 2019.
Experts who study depression say they've been cheered by preliminary study results on Sage-217. And…
Erin Brodwin  Â
J&J and Allergan are racing to shake up the $9 billion market for depression treatments for the first time in decades
One of the potential new drugs is inspired by ketamine but works in a more nuanced fashion (while k…
Erin Brodwin  Â
A crop of new depression treatments could yield the first new blockbuster drug in 30 years
Allergan's injectable drug, rapastinel, is in the last phase of clinical trials and has received a…
Lydia Ramsey,Erin Brodwin  Â
10 surprises that could rock biotech stocks in 2019, from success in Alzheimer's to a stumble in depression
Sage Therapeutics's depression treatment, Sage-217, acts on GABA, one of the neurotransmitters in t…